Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation.
BACKGROUND
Little is known about the significance of human herpesvirus 7 (HHV-7) in pediatric hematopoietic stem cell transplantation (HSCT).


OBJECTIVE
To evaluate children post autologous and allogeneic HSCT, with a positive PCR or immunohistochemistry for HHV-7 either from blood, cerebrospinal fluid (CSF) or any other pathology specimen. Clinical data for these patients were collected examining symptoms and signs, engraftment, acute infectious complications, graft versus host disease (GVHD) where applicable, and survival.


RESULTS
Between June 1999 and June 2003, 265 HSCT were performed in The Hospital for Sick Children, Toronto, allogeneic (n = 163) and autologous (n = 102). Nine children were positive for HHV-7 at a median of 21 days (range 16-27 days) post-HSCT. All had allogeneic transplantation. The most common underlying diagnosis was acute leukemia and 7 had matched unrelated donor (MUD) transplantation. Eight of the nine patients had grade II-IV acute GVHD and all of them had multiple infectious episodes with fungal, bacterial and other viral pathogens. Although not fully attributed to HHV-7, the clinical syndrome varied from fever, vomiting and diarrhea to septic shock. Four patients died due to GVHD and sepsis.


CONCLUSIONS
HHV-7 was uncommon post-HSCT. It was associated with severe GVHD and sepsis secondary to severe immunosuppression.
Khanani
Muhammad
M
Division of Hematology/Oncology/Bone Marrow Transplantation, The Hospital for Sick Children, University of Toronto, Canada.
Al-Ahmari
Ali
A
Tellier
Raymond
R
Allen
Upton
U
Richardson
Susan
S
Doyle
John J
JJ
Gassas
Adam
A
D000208:Acute Disease; D000293:Adolescent; D001769:Blood / Q000821:virology; D002555:Cerebrospinal Fluid / Q000821:virology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006086:Graft vs Host Disease / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation; D016199:Herpesvirus 7, Human / Q000302:isolation & purification*; D006801:Humans; D007150:Immunohistochemistry; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007239:Infections / Q000821:virology; D007938:Leukemia / Q000628:therapy; D008297:Male; D016133:Polymerase Chain Reaction; D013997:Time Factors; D014019:Tissue Donors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous